Literature DB >> 27602132

Rapid bone repair in a patient with lung cancer metastases to the spine using a novel herbal medicine: A case report.

Rong Pu1, Qianhong Zhao1, Zhimei Li2, Lingyan Zhang1, Xiaolu Luo2, Yangji Zeren2, Cui Yu3, Xianyong Li1.   

Abstract

The prognosis of lung carcinoma with metastasis to the bone, particularly to the spine, is poor. Chemotherapy and radiotherapy are established treatments for metastatic bone disease, but their effectiveness is unsatisfactory and bone repair following their use is slow and difficult. Medicine prepared from herbal extracts may be an alternative treatment option. The present study discusses the case of a 59-year-old patient diagnosed with squamous cell lung cancer (T2N3M1) in which first-line chemotherapy using docetaxel plus cisplatin failed. Heavy multiple bone metastases were detected in the T9 vertebra and sixth left rib, resulting in a high risk of pathological fracture. Eastern Cooperative Oncology Group (ECOG) and numerical rating scale (NRS) scores of pain were 2 and 4, respectively. A second-line treatment was chosen consisting of biological intracontrol treatment (BICT) plus bisphosphonates administered over 40 days. BICT is a therapy involving the use of herbal extracts (including ginseng, herba agrimoniae, hairyvein agrimonia herb, white flower patrinia herb and arginine) and palliative care. A partial positive response was reached following use of this regimen, particularly with regard to bone repair. A computed tomography scan revealed a 90% reduction in the broken area of the rib cage and T9 vertebra. The bone repair was rapid and almost complete. In addition, growth of the primary tumor in the right pulmonary hilar and metastasis in the mediastinal lymph nodes were stabilized following treatment. ECOG and NRS scores were decreased to 1 and 0, respectively, leading to an improved quality of life. Based on these results, the present study suggests that this herbal medicine-based regimen promotes bone repair and inhibits tumor growth, with low toxicity. However, the mechanism by which herbal medicine promotes rapid bone repair is unclear. Further studies are required to determine whether cells in the tumor microenvironment are stimulated to undergo re-differentiation by unidentified herbal substances.

Entities:  

Keywords:  biological intracontrol treatment; bone metastasis; herbal medicine; lung cancer; rapid repair

Year:  2016        PMID: 27602132      PMCID: PMC4998527          DOI: 10.3892/ol.2016.4879

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

Review 1.  Diagnosis and management of metastatic spine disease. A review.

Authors:  Daniel M Sciubba; Rory J Petteys; Mark B Dekutoski; Charles G Fisher; Michael G Fehlings; Stephen L Ondra; Laurence D Rhines; Ziya L Gokaslan
Journal:  J Neurosurg Spine       Date:  2010-07

2.  Evaluation and treatment of spinal metastatic disease.

Authors:  Shah-Nawaz M Dodwad; Jason Savage; Thomas J Scharschmidt; Alpesh Patel
Journal:  Cancer Treat Res       Date:  2014

3.  8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.

Authors: 
Journal:  Radiother Oncol       Date:  1999-08       Impact factor: 6.280

4.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

Authors:  William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

5.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

6.  FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer.

Authors:  Fen Zhao; Gang Ding; Wei Huang; Minghuan Li; Zheng Fu; Guoren Yang; Li Kong; Yan Zhang; Jinming Yu
Journal:  Clin Lung Cancer       Date:  2015-02-02       Impact factor: 4.785

Review 7.  Tumors of the osseous spine.

Authors:  Narayan Sundaresan; Stephano Boriani; Allen Rothman; Robert Holtzman
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

8.  Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis.

Authors:  Yasuaki Tokuhashi; Yasumitsu Ajiro; Natsuki Umezawa
Journal:  Spine (Phila Pa 1976)       Date:  2009-01-01       Impact factor: 3.468

9.  Predictors of survival in patients with bone metastasis of lung cancer.

Authors:  Hideshi Sugiura; Kenji Yamada; Takahiko Sugiura; Toyoaki Hida; Tetsuya Mitsudomi
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

10.  Long-term survival of a patient with lung cancer metastasis to the spine following surgical treatment combined with radiation and epithelial growth factor receptor inhibitor therapy: A case report.

Authors:  Songfeng Xu; Xiuchun Yu; Ming Xu
Journal:  Exp Ther Med       Date:  2014-11-07       Impact factor: 2.447

View more
  2 in total

Review 1.  Molecular mechanisms and clinical management of cancer bone metastasis.

Authors:  Manni Wang; Fan Xia; Yuquan Wei; Xiawei Wei
Journal:  Bone Res       Date:  2020-07-29       Impact factor: 13.567

2.  Severe Bilateral Breast Mucinous Carcinoma with Bilateral Lungs and Cutaneous Metastasis: A Case Report and Literature Review.

Authors:  Rong Pu; Yanchu Li; Xianyong Li
Journal:  Case Rep Oncol Med       Date:  2018-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.